SCHEMBL24333358

SCHEMBL24333358

Cc1ccc(OC2CCCC2)c(S(=O)(=O)NC(=O)c2cc3c(F)cc(N4CCC4)cc3o2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.36
MAPT P10636 4/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
FABP4 P15090 2/20 0.34
FABP5 Q01469 2/20 0.34
TP53 P04637 2/20 0.34
CASP1 P29466 1/20 0.34
LMNA P02545 1/20 0.33
HRH1 P35367 1/20 0.33
CCR3 P51677 1/20 0.33
P2RX4 Q99571 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
KAT6A Q92794 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333608 0.91 SCN9A (0.35) SCN9AMAPTSMN1; SMN2FABP4FABP5
SCHEMBL29469633 0.89 ALDH1A1 (0.36) SCN9AFABP4FABP5LMNA
SCHEMBL24333795 0.89 ALDH1A1 (0.36) SCN9AFABP4FABP5LMNA
SCHEMBL24333998 0.88 ALDH1A1 (0.34) SCN9AMAPTFABP4FABP5TP53
SCHEMBL29469700 0.88 ALDH1A1 (0.34) SCN9AMAPTFABP4FABP5TP53
SCHEMBL29469684 0.88 ALDH1A1 (0.36) SCN9ASMN1; SMN2LMNA
SCHEMBL24334016 0.88 ALDH1A1 (0.36) SCN9ASMN1; SMN2LMNA
SCHEMBL24333640 0.87 TSHR (0.43) MAPTSMN1; SMN2TP53LMNAMEN1
SCHEMBL24333981 0.87 MAPT (0.39) MAPTGAATP53LMNAMEN1
SCHEMBL29469701 0.87 TSHR (0.43) MAPTSMN1; SMN2TP53LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed